The Fremont Area Alzheimer's Collaboration supports University of Nebraska Medical Center as they see patients for Alzheimer's Study.
Our latest program work with Dr. Murman, UNMC, is called GeneMatch. It consists of a simple swab inside the cheek who through DNA can tell who will be subject to Alzheimer's 10-15 years from now. Those who sign up will get a kit from GeneMatch confidentially. Individuals between 50 and 75 are eligible.
The study called Alzheimer's Prevention Initiative Generation Study will involve 80 sites, it's lead by the Phoenix based Bahner Alzheimer's Institute and drug makers Novartis and Amgen. To quote Dr. Murman, "We are much more optimistic we'll be more successful at the earlier stage." And Dr. Petersen, Mayo Clinic says, "If we catch Alzheimer's in the early stages we may be able to delay its progress in terms of years." Dr. Murman also stated, "The medicines...would be like treating people to reduce cholesterol in order to prevent heart disease."
Marv Welstead, Honorary Chairperson